For the first time, a team of Princeton physicists have been able to link togeth...
The Allen Institute, the Chan Zuckerberg Initiative (CZI), and the University of...
East Hanover, NJ – December 07, 2023 – Kessler Foundation, a leader in rehabilit...
In the colorful world of avian courtship, the ruff (Calidris pugnax) is in a lea...
JMIR Mental Health, a premier SCIE/PubMed/Scopus-indexed, peer-reviewed journal ...
Racial discrimination and bias are painful realities and increasingly recognized...
URBANA, Ill. – When farmers harvest their grain, they can choose to sell it righ...
The National Science Foundation (NSF) has awarded The University of Texas at Arl...
COLUMBIA, Mo. — Many people associate virtual reality headsets with interactive ...
The U.S. Department of Energy’s SLAC National Accelerator Laboratory and Stanfor...
In a recent development, scientists have brought science fiction to life by crea...
In the highly competitive landscape of BTK inhibitors for blood cancer treatment...
Merus, a biopharmaceutical company, confronted a significant setback following a...
Merck KGaA’s foray into the competitive BTK inhibitor space has hit a roadblock,...
LY-3885125 is under clinical development by Eli Lilly and Co and currently in Ph...
Tislelizumab is under clinical development by BeiGene and currently in Phase III...
